Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10911466 | Lung Cancer | 2012 | 6 Pages |
Abstract
Staging FDG PET-CT is highly valuable in identifying second primary cancers or pre-malignant lesions in patients with NSCLC. When a second primary is detected on PET-CT, there is a high impact change in management in 27% of patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Michael Lin, Chaitanya Ambati,